Sinocelltech Ltd.
Clinical trials sponsored by Sinocelltech Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye drug SCT520FF hopes to tackle wet AMD Results expected Sep 2026 (estimated)
- New hope for painful skin condition: experimental drug enters mid-stage trial Results expected Mar 2027 (estimated)
- New lupus drug trial aims to tame the immune system Results expected Apr 2027 (estimated)
- New drug SCTB14 takes on standard immunotherapy in lung cancer showdown Results expected Jul 2027 (estimated)
-
Two-Drug combo targets tough Non-Hodgkin's lymphoma
Disease control Not yet recruitingResearchers are testing two experimental drugs, SCTB35 and SCTB41, in adults with B-cell non-Hodgkin's lymphoma that has returned or stopped responding to at least two prior treatments. Participants receive the drugs together, with or without chemotherapy, to find a safe dose and…
Phase 1/2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo takes on advanced cancers
Disease control Not yet recruitingThis early-phase trial is testing whether two experimental drugs, SCTB41 and SCTB39G, given together every three weeks, are safe and can shrink tumors in adults with advanced solid tumors that have not responded to standard treatments. The study will enroll 112 participants acros…
Phase 1/2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for lung cancer: experimental drug combo enters trial
Disease control Not yet recruitingThis study tests a new drug called SCTB41 combined with the chemotherapy docetaxel in 90 people with advanced non-small cell lung cancer that has worsened after prior treatment. The goal is to see if the combination is safe and works better than docetaxel alone. Participants will…
Phase 2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Not yet recruitingThis study tests two experimental drugs (SCTB41 and SCTB39-1) given together, sometimes with standard cancer therapy, in adults with advanced solid tumors that have not responded to prior treatments. The goal is to find safe doses and see if the combination can shrink tumors or s…
Phase 1/2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New lupus drug trial aims to tame the immune system
Disease control Not yet recruitingThis study tests a new medicine, SCTC21C, in 159 adults with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The goal is to see if the drug is safe and can reduce lupus symptoms. Participants must be on stable standard treatments and will receive the study drug …
Phase 1/2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC